Solid Biosciences earnings were -$124.7M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest SLDB earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$42.6M, up 30.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SLDB reported annual earnings of -$124.7M, with 29.9% growth. The next SLDB earnings date is May 13, 2025.
What were Solid Biosciences's earnings last quarter?
On SLDB's earnings call on Invalid Date, Solid Biosciences (NASDAQ: SLDB) reported Q4 2024 earnings per share (EPS) of -$1.02, up 2% year over year. Total SLDB earnings for the quarter were -$42.60 million. In the same quarter last year, Solid Biosciences's earnings per share (EPS) was -$1.00.
The next SLDB earnings date is Invalid Date. Add SLDB to your watchlist to be reminded of Solid Biosciences's next earnings date.
What was SLDB's earnings growth in the past year?
As of Solid Biosciences's earnings date in Invalid Date, Solid Biosciences's earnings has grown year over year. SLDB earnings in the past year totalled -$124.70 million.
Is Solid Biosciences profitable or losing money?
As of the last Solid Biosciences earnings report, Solid Biosciences is currently losing money. Solid Biosciences's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$124.70 million, a 29.87% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.